Skip to main content
Equibles

BVF INC/IL

Position in TCRX — TScan Therapeutics, Inc.

CIK 1056807 San Francisco, CA
Back to TCRX Full portfolio

Position in TCRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,453,004
-$166,928 QoQ
Shares Held
5,564,290
0.0% QoQ
Ownership
8.21%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#2
of 60 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in TCRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BVF INC/IL holds $3,440,293,274 across 41 Biotechnology names. TCRX ranks #35 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 2,965,160 $555,315,164
2 KYMR
Kymera Therapeutics, Inc.
 3,872,052 $444,008,202
3 MLTX
MoonLake Immunotherapeutics
 16,001,284 $311,544,999
4 GHRS
GH Research PLC
 8,650,158 $232,516,247
5 GPCR
Structure Therapeutics Inc.
 3,366,823 $180,697,390
6 NKTR
Nektar Therapeutics
 2,391,075 $166,920,945
7 MIRM
Mirum Pharmaceuticals, Inc.
 1,056,027 $123,629,080
8 XNCR
Xencor Inc
 7,133,720 $114,852,892

All Filings in TCRX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,453,004 5,564,290
2026-03-31 $5,619,932 5,564,290
2025-12-31 $5,226,074 5,226,074
2025-09-30 $9,511,454 5,226,074
2025-06-30 $7,577,807 5,226,074
2025-03-31 $6,747,474 4,889,474
2024-12-31 $9,088,000 2,989,474
2024-09-30 $14,887,580 2,989,474
2024-06-30 $17,488,422 2,989,474
2024-03-31 $23,736,423 2,989,474
2023-12-31 $17,428,633 2,989,474
2023-09-30 $7,653,053 2,989,474
2023-06-30 $7,473,685 2,989,474